Skip to main content

Table 4 Metabolic parameters at the end of the 6 month low and high dairy phases

From: Consumption of low-fat dairy foods for 6 months improves insulin resistance without adversely affecting lipids or bodyweight in healthy adults: a randomized free-living cross-over study

Variable

Endpoint

% change

Endpoint

% change

 

LD1

LD2

HD1

HD2

Body weight (kg)

86.2 ± 8.6

2.1 ± 1.2

87.0 ± 8.2

2.4 ± 1.3

Waist circumference (cm)

100.7 ± 13.3

1.0 ± 2.3

98.2 ± 7.3

1.2 ± 2.2

Total body fat (%)

45.4 ± 9.4

1.9 ± 2.1

45.0 ± 8.6

2.7 ± 2.3

Abdominal fat (%)

44.8 ± 9.02

2.1 ± 2.62

44.9 ± 7.82

1.2 ± 1.53

Systolic blood pressure (mm/Hg)

124.1 ± 16.2

2.5 ± 3.2

121.5 ± 14.6

4.8 ± 2.5

Diastolic blood pressure (mm/Hg)

78.5 ± 16.0

0.7 ± 2.6

76.6 ± 9.4

2.3 ± 2.6

Glucose (mmol/L)

5.2 ± 0.7

3.8 ± 1.5

5.2 ± 0.7

2.1 ± 1.9

Insulin (μU/mL)

16.2 ± 3.7

10.0 ± 3.2

14.8 ± 2.4*

2.5 ± 2.2¥

HOMA-IR

3.8 ± 1.3

16.5 ± 4.6

3.4 ± 0.9*

5.1 ± 2.8¥

Total cholesterol (mmol/L)

5.4 ± 0.9

1.1 ± 3.1

5.6 ± 0.8

3.1 ± 2.4

LDL-cholesterol (mmol/L)

3.3 ± 0.8

-1.2 ± 2.1

3.4 ± 0.8

3.9 ± 5.1

HDL-cholesterol (mmol/L)

1.4 ± 0.3

4.6 ± 2.3

1.4 ± 0.4

8.4 ± 3.4

Triglycerides (mmol/L)

1.8 ± 0.7

-0.05 ± 8.7

1.7 ± 0.6

-3.8 ± 10.1

ApoB (mg/dl)

90.7 ± 20.1

2.1 ± 1.8

92.5 ± 19.6

3.2 ± 4.5

ApoE (mg/dl)

5.4 ± 0.5

-2.5 ± 1.1

5.3 ± 0.8

-4.8 ± 2.6

Lp(a) (mg/dl)

37.3 ± 37.9

-9.4 ± 6.2

48.1 ± 13.1

-0.05 ± 7.4

ApoCII (mg/dl)

6.5 ± 1.7

10.1 ± 3.9

6.2 ± 1.9

2.6 ± 3.9

Metabolic rate (kJ/min)

2.8 ± 0.7

1.0 ± 3.9

2.7 ± 0.8

4.9 ± 4.3

Carbohydrate oxidation (g/min)

0.01 ± 0.04

3.6 ± 1.7

0.03 ± 0.05

6.8 ± 3.2

Fat oxidation (g/min)

0.07 ± 0.02

3.8 ± 0.02

0.06 ± 0.02

9.6 ± 10.9

  1. 1Endpoint values adjusted for baseline levels within period; mean ± SD; n = 23 LD; n = 23 HD.
  2. 2% change from baseline values were calculated using phase 1, d-1.
  3. *P < 0.05 compared with endpoint LD; ¥P < 0.05 compared with % change from baseline LD.